Andy Coravos is the chief executive officer and co-founder of Elektra Labs, building a digital medicine platform with an initial focus on digital biomarkers for decentralized clinical trials. She is also a member of the Harvard-MIT Center for Regulatory Sciences. She was formerly an Entrepreneur-in-Residence at the U.S. Food and Drug Administration working in the Digital Health Unit and focusing on the Pre-Cert program and policies around software and AI/ML. Previously, she worked as a software engineer at Akili Interactive Labs, a leading digital therapeutic company; worked at KKR, a private equity firm; and worked at McKinsey & Company, a management consulting firm, where she focused on the healthcare industry.
She serves on the board of the Digital Medicine Society and she’s an advisor to the Biohacking Village at DEF CON. Andy writes about software/tech, digital medicine, data privacy and governance rights and more on her blog. Her work has been published in WIRED, Quartz, Nature npj Digital Medicine, the Journal of Medical Internet Research and more.
